T Jalava
Overview
Explore the profile of T Jalava including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giatromanolaki A, Koukourakis M, Sivridis E, Gatter K, Trarbach T, Folprecht G, et al.
Br J Cancer
. 2012 Aug;
107(7):1044-50.
PMID: 22910317
Background: Pharmacological inhibitors of vascular endothelial growth factor (VEGF) receptors, like vatalanib, have been tested in randomised trials (CONFIRM (Colorectal Oral Novel therapy For the Inhibition of Angiogenesis and Retarding...
2.
Partanen K, Jalava T, Valaja J
Animal
. 2012 Mar;
1(3):389-401.
PMID: 22444337
Six 34-kg barrows were fitted with a post-valve T-caecum cannula and assigned to six dietary treatments according to a 6 × 5 change-over design to study how a mixture of...
3.
Joensuu H, de Braud F, Grignagni G, De Pas T, Spitalieri G, Coco P, et al.
Br J Cancer
. 2011 May;
104(11):1686-90.
PMID: 21540861
Background: Vatalanib (PTK787/ZK 222584) inhibits a few tyrosine kinases including KIT, platelet-derived growth factor receptors (PDGFRs) and vascular endothelial growth factor receptors (VEGFRs). We report efficacy and safety results of...
4.
McCloskey E, Johansson H, Oden A, Vasireddy S, Kayan K, Pande K, et al.
Osteoporos Int
. 2008 Nov;
20(5):811-7.
PMID: 19002369
Unlabelled: Fracture risk prediction can be enhanced by the concurrent assessment of other clinical risk factors. This study demonstrates that the estimation of an individual's 10-year probability of fracture by...
5.
Joensuu H, de Braud F, Coco P, De Pas T, Putzu C, Spreafico C, et al.
Ann Oncol
. 2007 Aug;
19(1):173-7.
PMID: 17698976
Background: We evaluated safety and efficacy of PTK787/ZK222584 (PTK/ZK), a novel tyrosine kinase inhibitor of KIT, platelet-derived growth factor receptors and vascular endothelial cell growth factor receptors (VEGFRs), in patients...
6.
Saarisalo E, Skytta E, Haikara A, Jalava T, Jaakkola S
J Appl Microbiol
. 2007 Jan;
102(2):327-36.
PMID: 17241337
Aim: Lactic acid bacteria (LAB) strains shown to have broad-spectrum antimicrobial activity were screened for potential as grass silage inoculants. The strains capable of rapidly lowering the pH of the...
7.
Venalainen E, Valaja J, Jalava T
Br Poult Sci
. 2006 Jun;
47(3):301-10.
PMID: 16787854
1. Performance, gait score (GS), tibial dyschondroplasia (TD), and tibia bone mineralisation and breaking strength were determined in 2880 male and female Ross 208 broilers fed on diets with two...
8.
Perttila S, Valaja J, Partanen K, Jalava T, Kiiskinen T, Palander S
Br Poult Sci
. 2001 Jun;
42(2):218-29.
PMID: 11421332
1. Effects of preservation method (drying or air-tight storage of whole grain and ensiling of rolled high-moisture grain) and beta-glucanase supplementation (Econase) on apparent ileal amino acid digestibilities and metabolisable...
9.
McCloskey E, Selby P, de Takats D, Bernard J, Davies M, Robinson J, et al.
Bone
. 2001 Mar;
28(3):310-5.
PMID: 11248662
The aim of this study was to determine whether clodronate reduced the incidence of vertebral fractures in patients with osteoporosis. We report here the interim analysis after 1 year of...
10.
Varvikko T, Vanhatalo A, Jalava T, Huhtanen P
J Dairy Sci
. 2000 Jan;
82(12):2659-73.
PMID: 10629814
Five rumen-cannulated Finnish Ayrshire cows were used in two 5 x 5 Latin square experiments designed to study the lactation and metabolic responses to increasing doses of DL-Met or L-Lys...